Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07134686
Recruiting
Implementation of a Joint Pulmonologist and ENT Consultation in the Care Pathway of Patients Suffering From Asthma and Chronic Rhinosinusitis With Nasal Polyposis: Effectiveness Compared With Consultations by Specialty (CON-PO Study).
Not applicable · France · 1 site
Registry update: 3 Aug 2026
NCT07673887
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Phase 3 · Belgium, China, Czechia, Germany, Spain, France, Italy, Japan, Poland, Puerto Rico, Portugal, Romania, United States · 132 sites
Registry update: 22 Oct 2026
NCT07852156
Recruiting
Cooling During Inpatient Rehabilitation in Persons With MS
Not applicable · Switzerland · 1 site
Registry update: 1 Oct 2026
NCT07668154
Recruiting
A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants
Phase 2 · China · 2 sites
Registry update: 9 Sept 2026
2025-524816-13-00
Recruiting
Phase 2 Study Evaluating the Safety and Efficacy of Neoadjuvant Amivantamab in Combination with Lazertinib or Chemotherapy in Resectable EGFR-Mutated Non-Small Cell Lung Cancer
Phase 2 · Spain · 3 sites
Registry update: 23 Oct 2026
NCT07738523
Recruiting
Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB Trial
Phase 2/3 · Spain · 1 site
Registry update: 31 Jul 2026
NCT07861191
Recruiting
RESET-INSPIRE Study: Insulin Sensitivity & Population Intervention With Real-time Evaluation Using CGM
Not applicable · Singapore · 1 site
Registry update: 6 Oct 2026
NCT07766980
Recruiting
Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients
Phase 2 · United States · 1 site
Registry update: 8 Oct 2026
NCT07736495
Recruiting
Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis
Phase 2/3 · Egypt · 1 site
Registry update: 30 Jul 2026
NCT07750886
Recruiting
Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
Not applicable · United States · 1 site
Registry update: 6 Aug 2026
NCT07681596
Recruiting
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Phase 1/2 · Australia, United States · 12 sites
Registry update: 15 Oct 2026
NCT07763197
Recruiting
Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)
Not applicable · United States · 1 site
Registry update: 13 Aug 2026
NCT07680946
Recruiting
Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
Phase 2 · United States · 2 sites
Registry update: 30 Oct 2026
NCT07698522
Recruiting
Digital Technology-Informed Stroke Rehabilitation
Not applicable · United States · 1 site
Registry update: 24 Sept 2026
NCT07588438
Recruiting
Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
Phase 4 · Paraguay · 1 site
Registry update: 19 May 2026
NCT07570862
Recruiting
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Phase 2 · United States · 12 sites
Registry update: 14 Sept 2026
NCT07488520
Recruiting
Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire
Phase 4 · Côte d’Ivoire · 2 sites
Registry update: 5 Oct 2026
NCT07581587
Recruiting
Investigation of the Effect of Inspiratory Muscle Training and Dual-Task Inspiratory Muscle Training on Cognitive Functions in Heart Failure
Not applicable · 1 site
Registry update: 30 Jul 2026
NCT07365306
Recruiting
Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Phase 2 · United States · 3 sites
Registry update: 28 Aug 2026
NCT07565220
Recruiting
Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
Phase 1 · United States · 1 site
Registry update: 18 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.